Vis enkel innførsel

dc.contributor.authorHollung, Sandra Julsen
dc.contributor.authorHägglund, Gunnar
dc.contributor.authorGaston, Mark
dc.contributor.authorSeid, Abdu Kedir
dc.contributor.authorLydersen, Stian
dc.contributor.authorAlriksson-Schmidt, Ann I.
dc.contributor.authorAndersen, Guro Lillemoen
dc.date.accessioned2024-06-24T12:44:28Z
dc.date.available2024-06-24T12:44:28Z
dc.date.created2021-01-05T16:53:15Z
dc.date.issued2021
dc.identifier.citationDevelopmental Medicine & Child Neurology. 2021, 63 (6), 721-728.en_US
dc.identifier.issn0012-1622
dc.identifier.urihttps://hdl.handle.net/11250/3135611
dc.description.abstractPoint prevalence and motor function of children and adolescents with cerebral palsy in Scandinavia and Scotland: a CP‐North studyen_US
dc.description.abstractAim: To describe the point prevalence of cerebral palsy (CP) and distribution of gross and fine motor function in individuals registered in a CP-North surveillance programme. Method: Aggregate data of individuals with CP aged 6 to 19 years, sex, CP subtype, and gross and fine motor function levels were collected from each programme. Overall and age-specific point prevalence of CP was calculated for each programme using 95% confidence intervals. Logistic regression was used to estimate prevalence and CP subtypes with age as the covariate variable. Pearson χ2 tests were used to compare the distributions of CP subtypes, Gross Motor Function Classification System (GMFCS) levels, and Manual Ability Classification System (MACS) levels by age and between programmes. Results: Among 3 759 138 individuals residing in Scandinavia and Scotland, 8278 had a diagnosis of CP (57–59% were males). The overall point prevalence of CP ranged from 2.13 to 2.32 per 1000 residents. Age-specific prevalence in each programme varied with the exception of Denmark. While the proportions of bilateral spastic CP were similar between programmes, there were variations in all other CP subtypes and in GMFCS and MACS levels. Interpretation: While the results of this study may reflect real differences in CP populations between countries, they may not be clinically relevant. The variations may be attributable to differences in the year when each programme was first established, different data collection methods, and country-specific governmental policies.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.subjectCerebral pareseen_US
dc.subjectCerebral Palsyen_US
dc.subjectForekomsten_US
dc.subjectOccurenceen_US
dc.titlePoint prevalence and motor function of children and adolescents with cerebral palsy in Scandinavia and Scotland: a CP‐North studyen_US
dc.title.alternativePoint prevalence and motor function of children and adolescents with cerebral palsy in Scandinavia and Scotland: a CP‐North studyen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber721-728en_US
dc.source.volume63en_US
dc.source.journalDevelopmental Medicine & Child Neurologyen_US
dc.source.issue6en_US
dc.identifier.doi10.1111/dmcn.14764
dc.identifier.cristin1865908
dc.relation.projectNordforsk: 82866en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal